Clinical research
20+ years of clinical discovery
Autonomic Health was built on more than two decades of clinical work identifying dysautonomia, dysregulation of the autonomic nervous system, as the hidden root cause behind dozens of modern chronic conditions.
The clinical architect
Dr. Ramesh Adiraju, MD, FACC
Dr. Ramesh Adiraju is an interventional cardiologist and the clinical architect of Autonomic Health’s dysautonomia research program. After fellowship training in Interventional Cardiology at Lankenau Hospital, Philadelphia (1993), he spent more than three decades in practice in Lower Bucks County, Pennsylvania, treating cardiovascular patients while building a parallel body of autonomic research. Over 20 years of clinical investigation led him to a unifying insight: that dysautonomia underlies the onset and perpetuation of a remarkably wide range of chronic conditions, from chronic heart failure and Type 2 diabetes to POTS, fibromyalgia, PTSD, and Long COVID. That insight is the foundation of Autonomic Health.
- MD, FACC
- Interventional Cardiology & Endovascular Specialist
- Founder & Medical Director, Dysautonomia Research Institute
- 33+ years Philadelphia-metro practice
- Top 10 Cardiologists recognition
Founded by Dr. Adiraju, the Dysautonomia Research Institute was folded into Autonomic Health, bringing its 21 years of clinical autonomic research and protocol development under the new company.
These outcomes are from Dr. Adiraju’s own clinical practice, a single clinic, over 20+ years. They are distinct from the broader real-world footprint of the clinical reference device, and they are not CloudANS performance figures.
Patients from top US medical centers
In their words
“It feels good to be a fully functioning human being again.”
Core hypothesis
The hypothesis that reframes chronic disease
A poorly functioning central autonomic system, a dysautonomia state, may be the root cause of many modern diseases including CHF, Type II diabetes, hypertension, ADHD, PTSD, migraine, and chronic fatigue.
Dr. Ramesh Adiraju
Modern medicine is organized by organ and specialty, but patients experience symptoms across systems at once. The autonomic nervous system is the body’s continuous control system, working through two branches, sympathetic and parasympathetic. In health they maintain autonomic coherence. When one chronically over- or under-fires, the result is dysautonomia. Two decades of work produced clinical protocols for assessing and treating it, which Autonomic Health extends into a wearable-native, AI-driven platform.
Foundational framework · Adiraju 2017
Central Clinical Autonomic Loop (CCAL)
Research areas
Orthostatic intolerance & circulatory dysregulation
POTS, syncope, and orthostatic hypotension.
Fatigue, post-viral & recovery disorders
ME/CFS and Long COVID.
Metabolic & vascular dysfunction
Type 2 diabetes, vasculopathy, and metabolic syndrome.
Multi-system symptom syndromes
Fibromyalgia, erythromelalgia, and IBS.
Neurohormonal regulation & disease progression
ADHD, PTSD, central sleep apnea, and RLS.
Cardiomyopathy & heart failure
Related cardiovascular research.
Clinical outcomes
Heart-failure reversal
In 200+ patients with severe left-ventricular dysfunction, the combined protocol achieved LV recovery to >45% EF; none required ICD device therapy.
Long COVID & ME/CFS
Identified specific autonomic abnormalities in Long COVID consistent with ME/CFS, with 250+ patients recovered using integrative modulation protocols.
Medication reduction
500+ Type 2 diabetes patients reduced insulin requirement; reductions also seen in ADHD stimulants, antihypertensive polypharmacy, and CPAP dependence.
These are Dr. Adiraju’s single-clinic clinical-practice outcomes over 20+ years, distinct from the clinical reference device’s multi-clinic footprint, and not CloudANS performance figures.
A 20-year research arc
First clinical application of ANS/RJ1000 testing
Early autonomic testing applied to complex cardiac and metabolic patients.
Dysautonomia Research Institute founded
A dedicated institute for ANS-directed diagnosis and treatment.
Cardiomyopathy & autonomic protocols
The 200+ advanced heart-failure series, managed with autonomic-directed protocols.
Dysautonomia & diabetes publication
Dysautonomia, Type 2 Diabetes and Vasculitis (J Indian College of Cardiology).
Dysautonomia & vascular framework
A novel approach to vasculitis and Type II diabetes (J Rheumatol Arthritic Dis).
Long COVID extension
The autonomic framework extended to post-viral illness and recovery.
The Autonomic Health platform
Wearable-native measurement and CAJAL, built on the same clinical protocols.
From research to Autonomic Health
Two decades at DRI
20+ years of dysautonomia research and protocol development at the Dysautonomia Research Institute.
The upstream control system
The ANS identified as the upstream control system, a unified explanation for diverse chronic conditions.
Wearables, AI, longitudinal care
Wearables, AI, and longitudinal care built on the same clinical protocols.
Publications & presentations
- 2017Dysautonomia: A Novel Approach to Understanding of Vasculitis and Type II DiabetesJournal of Rheumatology and Arthritic Diseases, 2017;2(3).
- 2016Dysautonomia, Type 2 Diabetes and VasculitisJournal of Indian College of Cardiology.View publication
- ChapterAutonomic Dysfunction and HypertensionHandbook of Interventions for Structural Heart and Peripheral Vascular Disease.
- 2001Preliminary Clinical Application of the ANS/RJ1000Mediterranean Journal of Pacing and Electrophysiology.
Explore the nervous-system layer of healthcare
Twenty years of clinical research, now a real-time autonomic health platform.